No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs111445108 |
chr1:161904748-161904749 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs370412140 |
chr1:161904821-161904822 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs548140190 |
chr1:161904884-161904885 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs114836668 |
chr1:161904916-161904917 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs527345073 |
chr1:161904927-161904928 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs535724255 |
chr1:161904963-161904964 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs555909326 |
chr1:161904971-161904972 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs547091737 |
chr1:161904983-161904984 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs570257585 |
chr1:161905024-161905025 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs572685987 |
chr1:161905047-161905048 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs539633388 |
chr1:161905049-161905050 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs373492152 |
chr1:161905087-161905088 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs550139048 |
chr1:161905101-161905102 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs570303204 |
chr1:161905135-161905136 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs146839083 |
chr1:161905144-161905145 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs186053979 |
chr1:161905228-161905229 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs190954809 |
chr1:161905267-161905268 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs182658888 |
chr1:161905339-161905340 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs535724416 |
chr1:161905376-161905377 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs114591250 |
chr1:161905424-161905425 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs186975608 |
chr1:161905429-161905430 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs111256263 |
chr1:161905435-161905436 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs576251305 |
chr1:161905505-161905506 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs541766617 |
chr1:161905571-161905572 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs140291677 |
chr1:161905603-161905604 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs527284759 |
chr1:161905626-161905627 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs192290459 |
chr1:161905630-161905631 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs145307805 |
chr1:161905648-161905649 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs532887762 |
chr1:161905698-161905699 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs137979131 |
chr1:161905742-161905743 |
Weak transcription Strong transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs570165296 |
chr1:161905757-161905758 |
Weak transcription Strong transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs7511775 |
chr1:161905779-161905780 |
Weak transcription Strong transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
33 |
rs16827987 |
chr1:161905792-161905793 |
Weak transcription Strong transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
34 |
rs182895357 |
chr1:161905825-161905826 |
Weak transcription Strong transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs188501478 |
chr1:161905839-161905840 |
Weak transcription Strong transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs77505094 |
chr1:161905893-161905894 |
Weak transcription Strong transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs565039100 |
chr1:161905929-161905930 |
Weak transcription Strong transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs537164296 |
chr1:161906031-161906032 |
Weak transcription Strong transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs556282274 |
chr1:161906051-161906052 |
Weak transcription Strong transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs114314826 |
chr1:161906077-161906078 |
Weak transcription Strong transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs542051963 |
chr1:161906089-161906090 |
Weak transcription Strong transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs58406542 |
chr1:161906091-161906092 |
Weak transcription Strong transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs111746347 |
chr1:161906098-161906099 |
Weak transcription Strong transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs113583246 |
chr1:161906099-161906100 |
Weak transcription Strong transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs75947510 |
chr1:161906100-161906101 |
Weak transcription Strong transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs10918224 |
chr1:161906113-161906114 |
Weak transcription Strong transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
47 |
rs572039619 |
chr1:161906146-161906147 |
Weak transcription Strong transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs76829621 |
chr1:161906153-161906154 |
Weak transcription Strong transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs10918225 |
chr1:161906205-161906206 |
Weak transcription Strong transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
50 |
rs193120472 |
chr1:161906289-161906290 |
Weak transcription Strong transcription Enhancers
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|